 | Up a level |
Journal Article
Dieras, V., Harbeck, N., Albain, K., Burris, H., Awada, A., Crivellari, D., Andre, F., Choi, Y. J., Huang, J. and Miller, K. D. (2010). A Phase Ib/II Trial of Trastuzumab-DM1 with Pertuzumab for Patients with HER2-Positive, Locally Advanced or Metastatic Breast Cancer: Interim Efficacy and Safety Results. Cancer Res., 70. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-7445
Hillmen, P., Soumerai, J., Zelenetz, A., Darif, M., Londhe, A., Xing, G., Huang, J., Lin, M., Byrd, J., Chanan-Khan, A., Furman, R., Hallek, M., Jones, J., Sharman, J., Ferrante, L., Reddy, V., Dreiling, L., Adewoye, H., Dubowy, R., Howes, A. and James, D. (2018). A Validated Risk Model for Overall Survival in Relapsed/Refractory Chronic Lymphocytic Leukaemia Applicable to Patients Treated with Novel Therapies and Standard of Care. Br. J. Haematol., 181. S. 75 - 76. HOBOKEN: WILEY. ISSN 1365-2141
Zheng, F., Luo, L., Wang, J., Huang, T., Huang, J., Wang, C., Hu, W. and Krischek, B. (2020). Non-vitamin-K oral anticoagulants may not significantly reduce the risk of fatal or disabling stroke compared with warfarin. Eur. J. Neurol., 27 (10). S. E57 - 1. HOBOKEN: WILEY. ISSN 1468-1331